Author Question: A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast ... (Read 74 times)

JGIBBSON · **on:** Jul 23, 2018

A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast cancer. Her medical record indicates she has cardiomyopathy and a cumulative dose of 300 mg/m2 of doxorubicin.

Which of the following measures would help limit the severity of the cardiomyopathy in this patient?
A) A reduced dose
B) A single large dose instead of multiple doses
C) The use of dexrazoxane in conjunction with doxorubicin
D) Meticulous monitoring during drug administration

Question 2

A 39-year-old woman is receiving doxorubicin for the treatment of cancer. After each treatment, the patient has acute nausea and vomiting accompanied by a slightly increased heart rate. The nurse will advise her to

A) perform relaxation techniques after the treatments.
B) make an appointment for cardiac function tests.
C) take the drug only at bedtime.
D) perform light exercise after administration of the drug.